Fundraising FoxImux
New York City, US · 1 known investors
Find your way into Imux
Sign up to see every warm intro you have to Imux
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Imux team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Immunic is a clinical-stage biopharmaceutical company developing oral small molecule treatments for neurologic and autoimmune diseases with unmet medical needs.
Founders & leadership
DH
Dr. Hella KohlhofCo-Founder, Chief Scientific Officer
JT
Jason TardioPresident and Chief Operating OfficerJason Tardio has held C-level pharmaceutical executive roles across specialty, rare disease, and large-market brands, with experience in general management, product launches, and cross-functional leadership in the United States, Latin America, and global markets.
Investors · 1
Frequently asked questions
- What does Imux do?
- Immunic is a clinical-stage biopharmaceutical company developing oral small molecule treatments for neurologic and autoimmune diseases with unmet medical needs.
- Who founded Imux?
- Imux was founded by Dr. Hella Kohlhof.
- Who are Imux's investors?
- Imux's investors include Fund+.
- Where is Imux headquartered?
- Imux is headquartered in New York City, US.